Announcements Trials
Browse Landscape

Phase

Phase 2 33Phase 1 7Phase NA 6Phase 1/2 5Phase 3 3Phase 2/3 2

Status

Completed 14Recruiting 9Terminated 5Withdrawn 3Unknown 3Active not recruiting 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 3Plasma cell 2Myeloid 2Gynecologic 1Classical hematology 1CNS 1

Conditions

Leukemia 3Myelodysplastic Syndromes 2Lymphoma 2Hematologic Neoplasms 2Uterine Cervical Neoplasms 1Neuroblastoma 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Immunologic Deficiency Syndromes 1Hodgkin Disease 1Anemia 1

Interventions

pembrolizumab 73Carboplatin 60Cyclophosphamide 59Nivolumab 52Paclitaxel 47Gemcitabine 44Cisplatin 43Dexamethasone 41Radiotherapy 36Rituximab 32Capecitabine 32Bevacizumab 29Docetaxel 28fludarabine 27atezolizumab 26Cytarabine 26avelumab 24venetoclax 23Trastuzumab 23Oxaliplatin 23Lenalidomide 23Cetuximab 23Azacitidine 23Ipilimumab 22Fluorouracil 22Temozolomide 21130-nm albumin-bound paclitaxel 21fludarabine phosphate 20Filgrastim 20Bortezomib 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × Terminated × Whole-Body Irradiation × Clear all
NCT01350258 2025-05-31

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

Thomas Jefferson University

Phase 1/2 Terminated
8 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

NCT00963872 2017-12-28

Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer

Masonic Cancer Center, University of Minnesota

Phase 1/2 Terminated
31 enrolled 24 charts
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes

NCT00058825 2016-11-07

HIMSUM

Baylor College of Medicine

Phase 1/2 Terminated
27 enrolled 13 charts
Other hematologic neoplasm

Hematologic Neoplasms

NCT01194609 2014-05-09

A Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer

Korea Cancer Center Hospital

Phase 1/2 Terminated
2 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡